Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances
Conclusion:
Our results do not support the hypothesis that switching to RPV improves cognitive function in patient under stable treatment with EFV. Nonetheless, improvements in neuropsychiatric symptoms, sleep quality and self-perceived cognition were observed.
Source: AIDS - Category: Infectious Diseases Tags: CLINICAL SCIENCE Source Type: research
More News: Anxiety | Atripla | Brain | Depression | HIV AIDS | Infectious Diseases | Neurology | Neuroscience | Science | Sleep Disorders | Sleep Medicine | Statistics | Truvada | Viread | Virology